Biotech News
Xeris Biopharma Announces Notice of Allowance From U.S. Patent and Trademark Office for New Patent Covering KEVEYIS®
Patent expected to provide intellectual property protection for Keveyis through 2039 Reinforces Xeris’ commitment to the primary periodic paralysis community and the patients who rely on Keveyis CHICAGO --(BUSINESS WIRE)--Jun. 11, 2026-- Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of